21 January 2025 : Clinical Research
Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion
Jingzheng Zeng1ABCDEF, Xiaoqin Sun1BDEF, Mingyan Luo2BDF, Yunju Rao1DF, Gu Gong1AG*DOI: 10.12659/MSM.945224
Med Sci Monit 2025; 31:e945224
Table 4 Postoperative adverse maternal events.
| Adverse event | Control (n=40) | BI (n=40) | BV (n=40) | P value |
|---|---|---|---|---|
| Nausea | 2 (5.0%) | 1 (2.5%) | 2 (5.0%) | 1.000 |
| Vomiting | 0 (0.0%) | 1 (2.5%) | 2 (5.0%) | 0.772 |
| Dizziness | 2 (5.0%) | 5 (12.5%) | 2 (5.0%) | 0.504 |
| Drowsiness | 2 (5.0%) | 6 (15.0%) | 3 (7.5%) | 0.378 |
| Itchy skin | 0 | 0 | 0 | – |
| Respiratory depression | 0 | 0 | 0 | – |
| Data are presented as percentages (proportions). Comparisons were performed using Pearson’s chi-squared test or Fisher’s exact test. | ||||